Condition: Localized Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT07302230

Sponsor: University of Washington

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: All

Inclusion Criteria:

• Adults (age >= 18 years)
• Prior diagnosis of non-muscle invasive bladder cancer (NMIBC), currently on surveillance or receiving maintenance intravesical therapy (including intravesical chemotherapy, immunotherapy)
• Classified as insufficiently active on the Physical Activity as a Vital Sign (PAVS) assessment
• Has an Android or Apple Smartphone/Tablet
• Ambulatory
• English-speaking
• Willing and able to participate in study activities and sign the informed consent form

Exclusion Criteria:

• Severe cognitive or memory impairment/dementia precluding ability to follow instructions or participate in survey assessments
• Inability to read or understand English
• Lack of access or lack of sufficient facility to use an Android or iOS smart device with the minimum criteria to run the ExerciseRx app
• Not receiving treatment at University of Washington (UW)
• Orthopedic, neurologic, or other problems that prevent safe ambulation and protocol adherence. Information on prior falls and other recent orthopedic or neurologic problems will be used to make judgment about protocol eligibility
• Inability/Unwillingness to participate in a personalized exercise program
• Current diagnosis with muscle-invasive or metastatic bladder cancer
• Uncontrolled or concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
• Lack of access or lack of sufficient facility to use an Android or iOS smart device with the minimum criteria for using the ExerciseRx app
• Participation in a clinical trial that does not permit enrollment in the EMPOWER trial

View trial on ClinicalTrials.gov